Evonik adds plant-based product BoruCare® Capsin to its portfolio for ruminants

New natural product for dairy cows based on red chili pepper

• Jointly developed with French company Heidi Botanicals

• BoruCare® Capsin increases milk yield in stressful phases

With a new, natural product rich in capsaicinoids, polyphenols, and flavonoids, Evonik helps the dairy industry address two major challenges: nutrient deficiency in early lactation and heat stress. BoruCare® Capsin has been developed in cooperation with Heidi Botanicals, a French specialist in plant-based products for livestock. The product was presented at SPACE 2025. It will be commercially available in Europe from Q4 2025.

“BoruCare® Capsin expands and complements our solutions for ruminants”, says Dr. Marion Hax, head of the Specialty Nutrition product line of Evonik Animal Nutrition. “With capsaicinoids as the main active compound in addition to polyphenols and flavonoids, it has multiple positive effects on the nutritional status, nutrient efficiency, and milk yield of dairy cows, particularly in stressful phases.”

In a proprietary process developed jointly with Heidi Botanicals, the product is derived from chili peppers without any solvent extraction. The process includes grinding the peppers, standardizing the capsaicinoids content to a minimum of 0.5%, and then encapsulation into a fatty matrix to remove pungency for excellent handling properties.

“Our unique process makes BoruCare® Capsin a particularly environmentally friendly product”, says Dr. Claudia Parys, responsible for the ruminant portfolio at Evonik Animal Nutrition. Another advantage of BoruCare® Capsin is that the whole chili peppers are used. Therefore, the product contains all secondary metabolites of the plants in addition to capsaicin.

Evonik goes beyond the boundaries of chemistry with its combination of innovative strength and leading technological expertise. The global chemical company, headquartered in Essen, Germany, is active in more than 100 countries and generated sales of €15.2 billion and earnings (adjusted EBITDA) of €2.1 billion in 2024. The common motivation of the approximately 32,000 employees: to provide customers with a decisive competitive advantage with tailor-made products and solutions as a superforce for industry, thereby improving people's lives. In all markets. Every day.

The Advanced Technologies segment includes Evonik’s market-leading businesses that leverage technological expertise and process know-how. These businesses feature high-performance polymers and crosslinking agents, hydrogen peroxide and silica, as well as feed ingredients. In 2024, the segment generated sales of €6.1 billion with around 8,000 employees.